Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Ignazio La Mantia's publication output changed over time?
ScholarIQpublication output · 2001–2024
Output grew0% over the shown period — from 1 works in 2001 to 1 in 2024.
1
1
1
1
2
5
1
2001200520202021202220232024
What are the most-cited papers on Ignazio La Mantia?
ScholarIQmost cited works
The Global Burden of Sepsis and Septic Shock
Luigi La Via, Giuseppe Sangiorgio, Stefania Stefani, Andrea Marıno, Giuseppe Nunnari, Salvatore Cocuzza, Ignazio La Mantia, Bruno Cacopardo, Stefano Stracquadanio, Serena Spampinato, Salvatore Lavalle, Antonino Maniaci
S4210219439. 2024229 CitationsOPEN ACCESS
Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps (<scp>CRSwNP</scp>): A multicentric observational Phase IV real‐life study (<scp>DUPIREAL</scp>)
Eugenio De Corso, Ernesto Pasquini, Matteo Trimarchi, Ignazio La Mantia, Fabio Pagella, Giancarlo Ottaviano, Massimiliano Garzaro, Carlotta Pipolo, Sara Torretta, Veronica Seccia, Elena Cantone, Andrea Ciofalo, Daniela Lucidi, Gian Luca Fadda, Pia Clara Pafundi, Stefano Settimi, Claudio Montuori, Francesca Anastasi, Giulio Pagliuca, Angelo Ghidini, Carlo Cavaliere, Marianna Maffei, Francesco Bussu, Stefania Gallo, Frank Rikki Canevari, Gaetano Paludetti, Jacopo Galli, Dupireal Italian Study Group
Allergy. 2023154 CitationsOPEN ACCESS
Earliest Clinical Manifestations and Natural History of Neurofibromatosis Type 2 (NF2) in Childhood: A Study of 24 Patients
Martino Ruggieri, Paola Iannetti, Agata Polizzi, Ignazio La Mantia, Alberto Spalice, O. Giliberto, Nunzio Platania, A. L. Gabriele, Valentina Erminia Albanese, Piero Pavone
Neuropediatrics. 2005139 Citations
Ultramicronized Palmitoylethanolamide and Luteolin Supplement Combinedwith Olfactory Training to Treat Post-COVID-19 OlfactoryImpairment: A Multi-Center Double-Blinded Randomized Placebo-Controlled Clinical Trial
Arianna Di Stadio, Luca D’Ascanio, Luigi Angelo Vaira, Elena Cantone, Pietro De Luca, Cristina Cingolani, Gaetano Motta, Giacomo De Riu, Federica Vitelli, Giuseppe Spriano, Marco de Vincentiis, Angelo Camaioni, Ignazio La Mantia, Fabio Ferreli, Michael Brenner
Current Neuropharmacology. 2022109 CitationsOPEN ACCESS
Autosomal Dominant Non-Syndromic Hearing Loss (DFNA): A Comprehensive Narrative Review
Mirko Aldè, Giovanna Cantarella, Diego Zanetti, Lorenzo Pignataro, Ignazio La Mantia, Luigi Maiolino, S Ferlito, Paola Di Mauro, Salvatore Cocuzza, Jérôme R. Lechien, Giannicola Iannella, François Simon, Antonino Maniaci
Biomedicines. 202363 CitationsOPEN ACCESS
Related on ScholarIQ
University of Catania
Institution
The Global Burden of Sepsis and Septic Shock
Paper
Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps (<scp>CRSwNP</scp>): A multicentric observational Phase IV real‐life study (<scp>DUPIREAL</scp>)
Paper
Earliest Clinical Manifestations and Natural History of Neurofibromatosis Type 2 (NF2) in Childhood: A Study of 24 Patients
Paper
Ultramicronized Palmitoylethanolamide and Luteolin Supplement Combinedwith Olfactory Training to Treat Post-COVID-19 OlfactoryImpairment: A Multi-Center Double-Blinded Randomized Placebo-Controlled Clinical Trial
Paper
Autosomal Dominant Non-Syndromic Hearing Loss (DFNA): A Comprehensive Narrative Review
Paper